Browse through our GU Cast library going back to March 2020

Renu Eapen

Our Library

Declan Murphy Declan Murphy

Shanghai GU Oncology Highlights Part 2

Part 2 of our GU Cast Conference Highlights from Shanghai including discussions with Dr Stephen Freedland (Los Angeles), Dr Liang Liang (Shaanxi), Dr Andrea Necchi (Milano), Dr Xiaojie Bian (Shanghai), and Dr Hongkai Wang (Shanghai). Special thanks to our Conference Highlights Partner, Bayer China, who set up an amazing GU Cast studio for us in Shanghai.

Read More
Declan Murphy Declan Murphy

The Sir Chris Hoy Effect | Why family history matters

Legendary British cyclist Sir Chris Hoy (48) recently shocked the world by announcing that he has progressive metastatic prostate cancer. His specialists have given him a 2-4 year life expectancy. The dreadful news that no prostate cancer patient wants to hear. Today, hosts Prof Declan Murphy and Dr Renu Eapen welcome their good mates A/Prof Ben Challacombe (Guy's Hospital, London), and A/Prof Daniel Moon (Peter MacCallum Cancer Centre, Melbourne) to the GU Cast studio, and patient advocate Andrei Norris who joins on Zoom to discuss the huge publicity this has generated, and the importance of family history in assessing men's risk of prostate cancer.

Read More
Declan Murphy Declan Murphy

PLND, ARPI Switch & De-Escalation | PROSPECT Podcast part 2

Part 2 Highlights from a GU Cast Live Event! Dr Kim Chi (Medical Oncologist, Vancouver) and Dr Carmen Mir (Urologist, Valencia) joined the PROSPECT meeting in Melbourne to discuss high-risk prostate cancer and mHSPC, along with many experts from around Australia. On the eve of the meeting over dinner, Declan Murphy led a GU Cast-themed panel discussion on five hot topics in prostate cancer, featuring snippets from GU Cast over the past few months.Part 2 today features controversies in PLND, the somewhat notorious ARPI switch control arm beloved of mCRPC trials, and the important topic of de-escalation in advanced prostate cancer.

Read More
Declan Murphy Declan Murphy

The MSKCC PLND RCT | Please explain!!!

What are we to make of this large RCT of extended vs standard pelvic lymph node dissection (PLND) for prostate cancer?? We chat with Dr Karim Touijer (MSKCC) and try to figure it out.

Read More
Declan Murphy Declan Murphy

PSMA Conundrums & Triplet vs Doublet | PROSPECT Podcast part 1

Highlights from a GU Cast Live Event! Dr Kim Chi (Medical Oncologist, Vancouver) and Dr Carmen Mir (Urologist, Valencia) joined the PROSPECT meeting in Melbourne to discuss high-risk prostate cancer and mHSPC, along with many experts from around Australia. On the eve of the meeting over dinner, Declan Murphy led a GU Cast-themed panel discussion on five hot topics in prostate cancer, featuring snippets from GU Cast over the past few months. Part 1 today features PSMA conundrums and triplet vs doublet therapy.

Read More
Declan Murphy Declan Murphy

Ten Years of ENZAMET | the gift that keeps on giving!

We really enjoyed listening to Ian Davis and Chris Sweeney tell the story of ENZAMET, one of our all-time favourite clinical trials, run by our favourite co-operative trial group, ANZUP. This is a Themed Podcast supported by our Gold Partner, Astellas.

Read More
Declan Murphy Declan Murphy

All your GU Highlights from #ESMO24!

Fantastic highlights from this year's best GU Oncology meeting, #ESMO24 in Barcelona! Our Conference Highlights are supported by our Partner, Bayer China

Read More

GU Cast Gold Partners